ArticleArchives of osteoporosis2026

Keeping bone resorption markers very low for 1 year after denosumab prevents bone loss at 2 years: the ReoLaus study.

Giovanni Liebich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.